Chronic Myeloid Leukemia, BCR-ABL1 Positive Clinical Trials

7 clinical trials for Chronic Myeloid Leukemia, BCR-ABL1 Positive across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases — RECRUITING · PHASE2
• Impact of Targeted Therapy on Cancer-Related Cognitive Impairment — RECRUITING
• Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies — RECRUITING · PHASE2
• HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant — RECRUITING · PHASE1
• CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant — RECRUITING · PHASE2
• Two Step Haplo With Radiation Conditioning — RECRUITING · PHASE2
• Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search